Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Schuster, Stephen J. [1 ]
Zhang, Jie [2 ]
Yang, Hongbo [3 ]
Agarwal, Abhijit [2 ]
Tang, Wenxi [3 ]
Prieto, Marcela Martinez [2 ]
Bollu, Vamsi [2 ]
Kuzan, David [2 ]
Maziarz, Richard [4 ]
Kersten, Marie Jose [5 ]
机构：
[1] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Anal Grp Inc, Boston, MA USA
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[5] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
ABCL; diffuse large B-cell lymphoma; CAR-T cell therapy; MAIC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-166
引用
收藏
页码：S380 / S381
页数：2
相关论文
共 50 条
  • [1] Comparative efficacy of tisagenlecleucel (tisa-cel) and lisocabtagene maraleucel (liso-cel) in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL).
    Schuster, Stephen J.
    Zhang, Jie
    Yang, Hongbo
    Agarwal, Abhijit
    Tang, Wenxi
    Martinez-Prieto, Marcela
    Bollu, Vamsi
    Ma, Qiufei
    Kuzan, David
    Maziarz, Richard T.
    Kersten, Marie Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison
    Schuster, Stephen J.
    Zhang, Jie
    Yang, Hongbo
    Agarwal, Abhijit
    Tang, Wenxi
    Martinez-Prieto, Marcela
    Bollu, Vamsi
    Kuzan, David
    Maziarz, Richard T.
    Kersten, Marie Jose
    LEUKEMIA & LYMPHOMA, 2022, 63 (04) : 845 - 854
  • [3] Lisocabtagene Maraleucel Approved for Use in Relapsed/Refractory Large B-Cell Lymphoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 175 - 175
  • [4] Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma
    Mohty, Razan
    Vanegas, Yenny Moreno
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 121 - 126
  • [5] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Bishop, Michael R.
    Tam, Constantine S.
    Waller, Edmund K.
    Borchmann, Peter
    McGuirk, Joseph P.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Andreadis, Charalambos
    Westin, Jason R.
    Fleury, Isabelle
    Bachanova, Veronika
    Foley, S. Ronan
    Ho, P. Joy p
    Mielke, Stephan
    Magenau, John M.
    Holte, Harald
    Pantano, Serafino
    Pacaud, Lida B.
    Awasthi, Rakesh
    Chu, Jufen
    Anak, Ozlem
    Salles, Gilles
    Maziarz, Richard T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01): : 45 - 56
  • [6] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
    Hideki Goto
    Shinichi Makita
    Koji Kato
    Kota Tokushige
    Taizo Fujita
    Koichi Akashi
    Koji Izutsu
    Takanori Teshima
    International Journal of Clinical Oncology, 2020, 25 : 1736 - 1743
  • [7] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
    Goto, Hideki
    Makita, Shinichi
    Kato, Koji
    Tokushige, Kota
    Fujita, Taizo
    Akashi, Koichi
    Izutsu, Koji
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1736 - 1743
  • [8] In Vivo Cellular Expansion of Lisocabtagene Maraleucel and Association With Efficacy and Safety in Relapsed/Refractory Large B-Cell Lymphoma
    Ogasawara, Ken
    Lymp, James
    Mack, Timothy
    Dell'Aringa, Justine
    Huang, Chang-pin
    Smith, Jeff
    Peiser, Leanne
    Kostic, Ana
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 81 - 89
  • [9] Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma
    Patrick, Donald L.
    Powers, Annette
    Jun, Monika Parisi
    Kim, Yeonhee
    Garcia, Jacob
    Dehner, Christine
    Maloney, David G.
    BLOOD ADVANCES, 2021, 5 (08) : 2245 - 2255
  • [10] LISOCABTAGENE MARALEUCEL FOR RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: FEASIBILITY, SAFETY AND EFFICACY IN A REAL-WORLD SETTING
    Portuguese, Andrew
    Liang, Emily
    Albittar, Aya
    Hirayama, Alexandre
    Till, Brian
    Cassaday, Ryan
    Lynch, Ryan
    Poh, Christina
    Milano, Filippo
    Chapuis, Aude
    Kiem, Hans-Peter
    Maloney, David G.
    Gauthier, Jordan
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 207 - 208
12345